Opportunity
Simpler Grants.gov #HT942526DMDRPIDA
Army Solicits Research Proposals for Duchenne Muscular Dystrophy Idea Development Award
Posted
June 17, 2026
Respond By
September 18, 2026
Identifier
HT942526DMDRPIDA
NAICS
541714, 541715
This opportunity is a research grant solicitation from the Dept. of the Army for the Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA). - Government Buyer: - Dept. of the Army, US Army Medical Research Acquisition Activity (USAMRAA) - OEMs and Vendors: - No specific OEMs or vendors are named, as this is a research grant opportunity - Products/Services Requested: - Early-stage, high-risk/high-reward research projects focused on Duchenne muscular dystrophy (DMD) - Projects must address therapies for DMD across the lifespan, including infants, toddlers, and nonambulatory individuals - Applications must include a well-formulated, testable hypothesis, strong scientific rationale, and preliminary data relevant to DMD - Unique or Notable Requirements: - Clinical trials or clinical trial aims are not permitted - Open to a wide range of applicants: domestic/foreign, for-profit/nonprofit, public/private institutions - Approximately five awards anticipated, each capped at $500,000 - Maximum period of performance is two years per award - Total available funding is $2,500,000
Description
The fiscal year 2026 Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) supports early-stage, high-risk/high-reward research with the potential to yield impactful data and new avenues of investigation to improve outcomes for individuals with Duchenne muscular dystrophy (DMD). The award encourages projects investigating therapies demonstrating efficacy across the lifespan, including infants, toddlers, and nonambulatory individuals. Applications must include a well-formulated, testable hypothesis based on strong scientific rationale and preliminary data relevant to DMD. Clinical trials or clinical trial aims are not allowed.